Catalyst Wire Dossier Catalyst Wire Dossier

5-HT4 receptor agonist (ACCORD trial)

· Alfasigma S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-HT4 receptor agonist (ACCORD trial), covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) [Phase 2]

See pricing